KNAPP: Executive orders – this is the brain of Trump on drugs
On July 24, US President Donald Trump signed four executive orders with an eye toward altering the way prescription drugs are priced and purchased in the United States. Three of the four orders embody good ideas that accord with the goals of think tanks supposedly supporting “free-market policy solutions” to America’s healthcare problems. Sally Pipes, president of one such think tank (the Pacific Research Institute), writes in opposition to those three orders, and in support of the fourth, anti-free-market order, […]
